Skip to content
By 2050, the number of people worldwide with cancer could increase 77%, according to a report published by the American Cancer Society in April […]
The future of cancer innovation – and the role of policy Read More »
Anonymous screening of 6.5 million people worldwide released on May 1 confirms the depth of the mental health challenges we face. Among the more
Mental Health Awareness Month: Anonymous screenings show depth of the challenges Read More »
The I am BIO podcast is bringing everything biotech-related to the ether, covering topics from AI and CRISPR to new drug developments, vaccines, and
I am BIO Podcast: 5 questions about biotech’s impact Read More »
History shows that women’s healthcare has often taken a back seat. Dating back centuries—to the early days of documentation—women have been left out of
Women’s Health Week: the evolution of women’s health screening Read More »
A variety of new treatments for multiple sclerosis (MS) have been introduced over the past 20 years, and there are some promising developments in
Science ready for ‘next step’ against multiple sclerosis Read More »
Emerging biotechs working on future cures need modernized regulation, policy to preserve and incentivize investment, and strong intellectual property protection, a biopharma CEO told
Sutro Biopharma CEO testifies on importance of access to capital, strong IP protection Read More »
For Raheem Mostert, Coach Chop was more than just a coach. As a young boy starting his first day of Pop Warner football at
Melanoma Research Foundation’s #GetNaked campaign Read More »
Is the accelerated approval pathway helping patients achieve better health outcomes or imposing on society medicines that don’t work? In BIO’s view, the pathway
Setting the record straight on accelerated approval Read More »
Kathleen Torkarski’s young daughter started experiencing pain and swelling in her ankles and feet six years ago. At first, the doctors had no answers.
Awareness is a major weapon in the war against arthritis Read More »
Sen. Bernie Sanders (I-Vt.), Chair of the Senate Health, Education, Labor, and Pensions Committee, announced that he is launching an investigation into the pricing
